tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Raghuram Selvaraju, 826 are a BUY (93.65%), 53 are a HOLD (6.01%), 3 are a SELL (0.34%).
Analyst Raghuram Selvaraju, currently employed carries an average stock price target met ratio of 29.97% that have a potential upside of 46.15% achieved within 158 days. Previously, Raghuram Selvaraju worked at HC WAINWRIGHT.
Raghuram Selvaraju’s has documented 1,659 price targets and ratings displayed on 96 stocks. The coverage was on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on ABEO, Abeona Therapeutics at 31-Oct-2024.
Analyst best performing recommendations are on EVOK (EVOKE PHARMA).
The best stock recommendation documented was for KZR (KEZAR LIFE SCIENCES) at 8/14/2024. The price target of $7 was fulfilled within 77 days with a profit of $6.39 (1047.54%) receiving and performance score of 136.04.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Sell
11 months 16 days ago
(20-Nov-2023)
1/3 (33.33%)
$-0.04 (-0.99%)
300
Hold
$1
$-0.07 (-6.54%)
$5
1 years 11 days ago
(25-Oct-2023)
4/21 (19.05%)
$0.29 (40.85%)
32
Sell
$1
$-0.07 (-6.54%)
$3.5
1 years 3 months 17 days ago
(19-Jul-2023)
8/11 (72.73%)
$-0.08 (-7.41%)
55
Hold
$1.25
$0.18 (16.82%)
$2
1 years 3 months 17 days ago
(19-Jul-2023)
2/5 (40%)
$0.17 (15.74%)
215
Buy
$10
2 years 4 months 14 days ago
(22-Jun-2022)
13/47 (27.66%)
$6.81 (213.48%)
194
Which stock is Raghuram Selvaraju is most bullish on?
Which stock is Raghuram Selvaraju is most reserved on?
What Year was the first public recommendation made by Raghuram Selvaraju?
